Manufacturing: Page 18
-
Marken expands in Philadelphia, seeing higher biopharma demand
The biopharma-focused subsidiary of UPS will add a new GMP-compliant storage and distribution center near the Philadelphia airport.
By Kristin Jensen • Feb. 7, 2019 -
Tris Pharma's ibuprofen recall grows
The drugmaker is now recalling three more lots of product, adding to its production woes and the industry's larger problems with ibuprofen.
By Jacob Bell • Feb. 7, 2019 -
Brian Tucker/BioPharma Dive
Deep DivePharma is shuffling around jobs, but a skills gap threatens the process
Drugmakers have found difficulty luring employees who can work with the latest technologies away from the likes of Amazon and Google, for instance.
By Jacob Bell • Feb. 4, 2019 -
J&J inks deal with MeiraGTx for retinal disease gene therapies
The early-stage deal is a sign of growing interest from pharma in advancing gene therapy development, analysts said.
By Suzanne Elvidge • Feb. 1, 2019 -
Hitachi Chemical buys cell therapy-focused CDMO in Germany
The deal will add two manufacturing sites in Munich to Hitachi's portfolio, which already includes sites in the U.S. and Japan.
By Andrew Dunn • Jan. 31, 2019 -
Lonza promotes biopharma head to CEO spot
Marc Funk, currently COO of Lonza's Pharma and Biotech unit, will take over for Richard Ridinger in March.
By Ned Pagliarulo • Jan. 31, 2019 -
Novartis touts record year for manufacturing changes, but Kymriah still an overhang
Despite 16 plant transformations in 2018, Novartis foresees more work ahead as the company tries to strengthen production capabilities.
By Jacob Bell • Jan. 31, 2019 -
FDA zeroes in on potential causes of blood pressure med contamination
Scientists at the FDA have developed new tests to detect NDMA impurities contaminating some valsartan and other angiotensin II receptor blockers.
By Suzanne Elvidge • Jan. 28, 2019 -
Lonza begins second-gen supply of Portola's Andexxa
Recent FDA approval of Portola's new manufacturing process for the reversal agent has allowed the biotech to launch the drug more broadly in the U.S.
By Ned Pagliarulo • Jan. 24, 2019 -
SAP debuts blockchain solution for counterfeit drugs
Manufacturers can store unique data via blockchain, and consumers can access the information by scanning the products with their smartphones.
By Matt Leonard • Jan. 23, 2019 -
How product recalls spread through the supply chain
Traceability and inventory planning can help supply chain managers weather the storm of a recall.
By Barry Hochfelder • Jan. 22, 2019 -
Novartis, Novo Nordisk stockpile medicines as risk of no-deal Brexit rises
The Danish diabetes drugmaker is working to increase its stockpiles of insulin, while Novartis warned of "hugely impactful" disruption.
By Matt Leonard • Updated Jan. 25, 2019 -
Boehringer building out biologics manufacturing in China
The expansion of Boehringer's OASIS plant includes another bioreactor and the infrastructure to support two 2,000-liter single-use bioreactor production lines.
By Jacob Bell • Jan. 17, 2019 -
AmerisourceBergen subsidiary laying off hundreds at compounding plant
The company will cut about half its workforce at a Tennessee-based facility, which has been suspended due to concerns flagged by the FDA last year.
By Suzanne Elvidge • Jan. 17, 2019 -
EPA: Pharmaceuticals in reverse supply chain are hazardous waste
A new regulation could prompt uncertainty as players in the pharmaceutical supply chain evaluate compliance.
By Gary Wollenhaupt • Jan. 14, 2019 -
FDA expands excepted activities as government shutdown drags on
As days stretch into weeks, Commissioner Scott Gottlieb and his agency are battling to not let the shutdown hurt food and drug safety.
By Suzanne Elvidge • Jan. 14, 2019 -
Akorn's drug pipeline 'held hostage' with FDA warning letter
The agency detailed numerous violations against the generic manufacturer's plant in Decatur, Illinois.
By Kristin Jensen • Jan. 10, 2019 -
Yujin Kim/BioPharma Dive
Q&ASpark looks at scale, manufacturing as gene therapy matures
Though Luxturna only recently hit the market, Spark is already at work validating new ways of scaling up manufacturing.
By Jacob Bell • Jan. 10, 2019 -
Catalent to invest $200M in biologics manufacturing, creating 300 US jobs
The move follows a $14 million investment in Bloomington, Indiana, to boost packaging offerings.
By Kristin Jensen • Jan. 8, 2019 -
Sarepta inks deal to bolster gene therapy manufacturing
An agreement with Aldevron may help the biotech avoid setbacks like the short-lived clinical hold it received on a gene therapy candidate last year.
By Suzanne Elvidge • Jan. 3, 2019 -
Our 10 best stories of 2018
Pharma boards, cell therapy, AI and cancer drug ads feature in BioPharma Dive's top articles of the past 12 months.
By Ned Pagliarulo • Dec. 21, 2018 -
Novartis seeks to acquire French CAR-T contract manufacturer
CellforCure already works with Novartis on clinical production of Kymriah, a therapy that has hit manufacturing hurdles in its rollout.
By Ned Pagliarulo • Dec. 20, 2018 -
Recipharm considering closing UK plant, could affect 140 workers
The CEO said the facility in Greater Manchester, England, had "no likely prospect" to deliver "acceptable return in the medium term."
By Andrew Dunn • Dec. 20, 2018 -
Sen. Warren proposes government manufacture generics
Democratic Sen. Elizabeth Warren is pitching a radical way to cut drug prices for the U.S. budget — the government manufacturing its own generics.
By Suzanne Elvidge • Dec. 19, 2018 -
Sponsored by MilliporeSigma
New education program to accelerate industry next-gen processing
Employee training is critical as organizations implement next-generation technologies to create new products and streamline their operations across departments.
Dec. 17, 2018
Previous
